Covered recipient · General Payments record
ANNDREA BOYER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$879.27
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $760.17 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $406.16 | 18 |
| Medtronic, Inc. | $171.40 | 8 |
| Indivior Inc. | $50.54 | 2 |
| Lilly USA, LLC | $46.41 | 3 |
| Abbott Laboratories | $37.22 | 2 |
| Mylan Specialty L.P. | $18.12 | 1 |
| Acerta Pharma LLC | $16.25 | 1 |
| Inspire Medical Systems, Inc. | $14.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.75 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125200352 | CMS |
| Abbott Laboratories | $18.47 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125200354 | CMS |
| ABBVIE INC. | $28.36 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809818 | CMS |
| ABBVIE INC. | $9.95 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809820 | CMS |
| ABBVIE INC. | $21.03 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809822 | CMS |
| ABBVIE INC. | $29.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809824 | CMS |
| ABBVIE INC. | $29.16 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809826 | CMS |
| ABBVIE INC. | $22.58 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809828 | CMS |
| ABBVIE INC. | $13.70 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809830 | CMS |
| ABBVIE INC. | $12.65 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809832 | CMS |
| ABBVIE INC. | $20.93 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809834 | CMS |
| ABBVIE INC. | $23.70 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809836 | CMS |
| ABBVIE INC. | $20.40 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809838 | CMS |
| ABBVIE INC. | $24.79 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809840 | CMS |
| ABBVIE INC. | $28.80 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809842 | CMS |
| ABBVIE INC. | $20.86 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809844 | CMS |
| ABBVIE INC. | $23.62 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809846 | CMS |
| ABBVIE INC. | $26.05 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809848 | CMS |
| ABBVIE INC. | $25.33 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809850 | CMS |
| ABBVIE INC. | $24.79 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106809852 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.25 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104413905 | CMS |
| Indivior Inc. | $22.85 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545031 | CMS |
| Indivior Inc. | $27.69 | 07/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545033 | CMS |
| Inspire Medical Systems, Inc. | $14.07 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148137067 | CMS |
| Lilly USA, LLC | $15.43 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135557796 | CMS |
| Lilly USA, LLC | $14.59 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135535372 | CMS |
| Lilly USA, LLC | $16.39 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135537044 | CMS |
| Medtronic, Inc. | $21.38 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979055 | CMS |
| Medtronic, Inc. | $23.18 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979057 | CMS |
| Medtronic, Inc. | $23.39 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979059 | CMS |
| Medtronic, Inc. | $19.32 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979061 | CMS |
| Medtronic, Inc. | $20.10 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979063 | CMS |
| Medtronic, Inc. | $22.08 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979065 | CMS |
| Medtronic, Inc. | $22.97 | 11/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979067 | CMS |
| Medtronic, Inc. | $18.98 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116979069 | CMS |
| Mylan Specialty L.P. | $18.12 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147295671 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.